Koers Amedica Corporation Nasdaq
Aandelen
US0234352096
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 3,3 mln. 3,07 mln. | Omzet 2025 * | 3,91 mln. 3,63 mln. | Marktkapitalisatie | 5,75 mln. 5,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -14 mln. -13,01 mln. | Nettowinst (verlies) 2025 * | -14 mln. -13,01 mln. | EV/omzet 2024 * | 1,74 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,47 x |
K/w-verhouding 2024 * |
-0,52
x | K/w-verhouding 2025 * |
-0,85
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
B. Bal
CEO | Chief Executive Officer | 61 | 08-02-12 |
Ryan Bock
CTO | Chief Tech/Sci/R&D Officer | - | - |
David O’Brien
COO | Chief Operating Officer | 59 | 01-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Stookey
BRD | Director/Board Member | 53 | 06-10-14 |
Jeffrey White
BRD | Director/Board Member | 70 | 28-01-14 |
David Truetzel
BRD | Director/Board Member | 67 | 01-09-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,58% | 10,91 mld. | |
+2,17% | 8,93 mld. | |
+22,75% | 7,57 mld. | |
+33,99% | 5,34 mld. | |
+8,12% | 3,43 mld. | |
-8,48% | 2,81 mld. | |
-5,07% | 2,23 mld. | |
-4,22% | 2,13 mld. | |
-20,87% | 1,84 mld. |